Literature DB >> 24288131

Peroxisome proliferator-activated receptor γ regulates genes involved in insulin/insulin-like growth factor signaling and lipid metabolism during adipogenesis through functionally distinct enhancer classes.

Frédérik Oger1, Julie Dubois-Chevalier, Céline Gheeraert, Stéphane Avner, Emmanuelle Durand, Philippe Froguel, Gilles Salbert, Bart Staels, Philippe Lefebvre, Jérôme Eeckhoute.   

Abstract

The nuclear receptor peroxisome proliferator-activated receptor (PPAR) is a transcription factor whose expression is induced during adipogenesis and that is required for the acquisition and control of mature adipocyte functions. Indeed, PPAR induces the expression of genes involved in lipid synthesis and storage through enhancers activated during adipocyte differentiation. Here, we show that PPAR also binds to enhancers already active in preadipocytes as evidenced by an active chromatin state including lower DNA methylation levels despite higher CpG content. These constitutive enhancers are linked to genes involved in the insulin/insulin-like growth factor signaling pathway that are transcriptionally induced during adipogenesis but to a lower extent than lipid metabolism genes, because of stronger basal expression levels in preadipocytes. This is consistent with the sequential involvement of hormonal sensitivity and lipid handling during adipocyte maturation and correlates with the chromatin structure dynamics at constitutive and activated enhancers. Interestingly, constitutive enhancers are evolutionary conserved and can be activated in other tissues, in contrast to enhancers controlling lipid handling genes whose activation is more restricted to adipocytes. Thus, PPAR utilizes both broadly active and cell type-specific enhancers to modulate the dynamic range of activation of genes involved in the adipogenic process.

Entities:  

Keywords:  Adipogenesis; Chromatin Modification; DNA Methylation; Epigenomics; Insulin/Insulin-like Growth Factor Signaling; Peroxisome Proliferator-activated Receptor (PPAR); Transcription Enhancers; Transcription Regulation

Mesh:

Substances:

Year:  2013        PMID: 24288131      PMCID: PMC3887199          DOI: 10.1074/jbc.M113.526996

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  58 in total

1.  SnapShot: adipocyte life cycle.

Authors:  Yuwei Jiang; A-Young Jo; Jonathan M Graff
Journal:  Cell       Date:  2012-07-06       Impact factor: 41.582

2.  Computational analysis of genome-wide DNA methylation during the differentiation of human embryonic stem cells along the endodermal lineage.

Authors:  Lukas Chavez; Justyna Jozefczuk; Christina Grimm; Jörn Dietrich; Bernd Timmermann; Hans Lehrach; Ralf Herwig; James Adjaye
Journal:  Genome Res       Date:  2010-08-27       Impact factor: 9.043

3.  Dynamic readers for 5-(hydroxy)methylcytosine and its oxidized derivatives.

Authors:  Cornelia G Spruijt; Felix Gnerlich; Arne H Smits; Toni Pfaffeneder; Pascal W T C Jansen; Christina Bauer; Martin Münzel; Mirko Wagner; Markus Müller; Fariha Khan; H Christian Eberl; Anneloes Mensinga; Arie B Brinkman; Konstantin Lephikov; Udo Müller; Jörn Walter; Rolf Boelens; Hugo van Ingen; Heinrich Leonhardt; Thomas Carell; Michiel Vermeulen
Journal:  Cell       Date:  2013-02-21       Impact factor: 41.582

4.  DNA methylation status predicts cell type-specific enhancer activity.

Authors:  Malgorzata Wiench; Sam John; Songjoon Baek; Thomas A Johnson; Myong-Hee Sung; Thelma Escobar; Catherine A Simmons; Kenneth H Pearce; Simon C Biddie; Pete J Sabo; Robert E Thurman; John A Stamatoyannopoulos; Gordon L Hager
Journal:  EMBO J       Date:  2011-06-24       Impact factor: 11.598

Review 5.  Mechanisms and functions of Tet protein-mediated 5-methylcytosine oxidation.

Authors:  Hao Wu; Yi Zhang
Journal:  Genes Dev       Date:  2011-12-01       Impact factor: 11.361

6.  A unique chromatin signature uncovers early developmental enhancers in humans.

Authors:  Alvaro Rada-Iglesias; Ruchi Bajpai; Tomek Swigut; Samantha A Brugmann; Ryan A Flynn; Joanna Wysocka
Journal:  Nature       Date:  2010-12-15       Impact factor: 49.962

7.  Comparative epigenomic analysis of murine and human adipogenesis.

Authors:  Tarjei S Mikkelsen; Zhao Xu; Xiaolan Zhang; Li Wang; Jeffrey M Gimble; Eric S Lander; Evan D Rosen
Journal:  Cell       Date:  2010-10-01       Impact factor: 41.582

8.  PPARbeta/delta potentiates PPARgamma-stimulated adipocyte differentiation.

Authors:  Kimihiko Matsusue; Jeffrey M Peters; Frank J Gonzalez
Journal:  FASEB J       Date:  2004-07-09       Impact factor: 5.191

9.  Rapid cellular turnover in adipose tissue.

Authors:  Alessandra Rigamonti; Kristen Brennand; Frank Lau; Chad A Cowan
Journal:  PLoS One       Date:  2011-03-02       Impact factor: 3.240

10.  Global mapping of cell type-specific open chromatin by FAIRE-seq reveals the regulatory role of the NFI family in adipocyte differentiation.

Authors:  Hironori Waki; Masahiro Nakamura; Toshimasa Yamauchi; Ken-ichi Wakabayashi; Jing Yu; Lisa Hirose-Yotsuya; Kazumi Take; Wei Sun; Masato Iwabu; Miki Okada-Iwabu; Takanori Fujita; Tomohisa Aoyama; Shuichi Tsutsumi; Kohjiro Ueki; Tatsuhiko Kodama; Juro Sakai; Hiroyuki Aburatani; Takashi Kadowaki
Journal:  PLoS Genet       Date:  2011-10-20       Impact factor: 5.917

View more
  20 in total

Review 1.  The increasingly complex regulation of adipocyte differentiation.

Authors:  Sylvia P Poulos; Michael V Dodson; Melinda F Culver; Gary J Hausman
Journal:  Exp Biol Med (Maywood)       Date:  2015-12-07

2.  GROWTH AND DEVELOPMENT SYMPOSIUM: STEM AND PROGENITOR CELLS IN ANIMAL GROWTH: The regulation of beef quality by resident progenitor cells1.

Authors:  Xing Fu; Chaoyang Li; Qianglin Liu; Kenneth W McMillin
Journal:  J Anim Sci       Date:  2019-05-30       Impact factor: 3.159

Review 3.  Distinct but complementary contributions of PPAR isotypes to energy homeostasis.

Authors:  Vanessa Dubois; Jérôme Eeckhoute; Philippe Lefebvre; Bart Staels
Journal:  J Clin Invest       Date:  2017-04-03       Impact factor: 14.808

Review 4.  The ubiquitous transcription factor CTCF promotes lineage-specific epigenomic remodeling and establishment of transcriptional networks driving cell differentiation.

Authors:  Julie Dubois-Chevalier; Bart Staels; Philippe Lefebvre; Jérôme Eeckhoute
Journal:  Nucleus       Date:  2015       Impact factor: 4.197

Review 5.  PPARγ and the global map of adipogenesis and beyond.

Authors:  Martina I Lefterova; Anders K Haakonsson; Mitchell A Lazar; Susanne Mandrup
Journal:  Trends Endocrinol Metab       Date:  2014-04-29       Impact factor: 12.015

6.  The optimal corepressor function of nuclear receptor corepressor (NCoR) for peroxisome proliferator-activated receptor γ requires G protein pathway suppressor 2.

Authors:  Chun Guo; Yali Li; Chien-Hung Gow; Madeline Wong; Jikun Zha; Chunxia Yan; Hongqi Liu; Yongjun Wang; Thomas P Burris; Jinsong Zhang
Journal:  J Biol Chem       Date:  2014-12-17       Impact factor: 5.157

Review 7.  Transgenerational inheritance of prenatal obesogen exposure.

Authors:  Amanda S Janesick; Toshihiro Shioda; Bruce Blumberg
Journal:  Mol Cell Endocrinol       Date:  2014-09-16       Impact factor: 4.102

8.  A dynamic CTCF chromatin binding landscape promotes DNA hydroxymethylation and transcriptional induction of adipocyte differentiation.

Authors:  Julie Dubois-Chevalier; Frédérik Oger; Hélène Dehondt; François F Firmin; Céline Gheeraert; Bart Staels; Philippe Lefebvre; Jérôme Eeckhoute
Journal:  Nucleic Acids Res       Date:  2014-09-02       Impact factor: 16.971

9.  Twist 1 regulates the expression of PPARγ during hormone-induced 3T3-L1 preadipocyte differentiation: a possible role in obesity and associated diseases.

Authors:  Wanshan Ma; Sumei Lu; Tao Sun; Xiangdong Wang; Yongmei Ma; Xiaoli Zhang; Ruxing Zhao; Yunshan Wang
Journal:  Lipids Health Dis       Date:  2014-08-16       Impact factor: 3.876

Review 10.  Long non-coding RNAs in metabolic disorders: pathogenetic relevance and potential biomarkers and therapeutic targets.

Authors:  B Alipoor; S Nikouei; F Rezaeinejad; S-N Malakooti-Dehkordi; Z Sabati; H Ghasemi
Journal:  J Endocrinol Invest       Date:  2021-04-01       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.